Filing Details
- Accession Number:
- 0001209191-22-040108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-01 15:11:10
- Reporting Period:
- 2022-06-01
- Accepted Time:
- 2022-07-01 15:11:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-01 | 25 | $2.05 | 16,496 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-02 | 25 | $2.08 | 16,521 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-03 | 25 | $2.09 | 16,546 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-06 | 27 | $2.07 | 16,573 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-07 | 20 | $2.08 | 16,593 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-08 | 27 | $2.12 | 16,620 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-09 | 27 | $2.09 | 16,647 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-10 | 27 | $2.04 | 16,674 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-13 | 27 | $2.01 | 16,701 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-14 | 27 | $2.02 | 16,728 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-15 | 27 | $1.98 | 15,755 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-16 | 27 | $1.95 | 16,782 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-17 | 27 | $1.94 | 16,809 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-21 | 28 | $1.97 | 16,837 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-22 | 25 | $1.99 | 16,862 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-23 | 28 | $2.01 | 16,890 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-24 | 28 | $2.11 | 16,918 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-27 | 7 | $2.06 | 16,925 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-28 | 23 | $2.06 | 16,948 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-29 | 28 | $2.11 | 16,976 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-30 | 28 | $2.08 | 17,004 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.